ABLC 2018, 28 February – 2 March 2018, Washington, DC

27 February 2018

Meet PEACCEL at ABLC 2018.

Rudy PANDJAITAN (Senior Director – Business Development) will be representing PEACCEL at this event.

PRAXISforum Enzymes for Industrial Applications 2018, 6-7 February 2018, Frankfurt, Germany

30 January 2018

Meet PEACCEL at PRAXISforum Enzymes for Industrial Applications 2018.

Rudy PANDJAITAN (Senior Director – Business Development) will be representing PEACCEL at this event.

PepTalk, 8-12 January 2018, San Diego, California

8 January 2018

Meet PEACCEL at PepTalk: The Protein Science Week.

Meet Rudy PANDJAITAN to discover our poster entitled

“Disruptive mixed in vitro-in silico approach for protein engineering and screening: Case study of the engineering of the enantioselectivity of an epoxide hydrolase“ 

and 

“Automatic reconstruction and modelling of biocatalyst systems for the production of specific biochemical compounds“.

PEACCEL and SeSaM-Biotech sign enzyme development collaboration

29 November 2017

Peaccel and SeSaM-Biotech today jointly announced the signature of a collaboration agreement. Under the agreement, PEACCEL and SeSaM-Biotech will develop improved enzyme variants of a commercially important enzyme family…

Paper alert: Knowledge-based prediction of protein backbone conformation using a structural alphabet

22 November 2017

PEACCEL’s latest paper is available on https://doi.org/10.1371/journal.pone.0186215

Enzyme Engineering XXIV, 24-28 September 2017, Toulouse, France

22 September 2017

Meet PEACCEL at Enzyme Engineering XXIV.

Meet Matthieu NG FUK CHONG and Rudy PANDJAITAN to discover our poster entitled “Disruptive mixed in vitro-in silico approach for protein engineering and screening: Case study of the engineering of the enantioselectivity of an epoxide hydrolase“.